What is the recommended approach to resuscitate a patient presenting with shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Resuscitation of a Shock Patient

Begin immediate resuscitation with at least 30 mL/kg of IV crystalloid fluid within the first 3 hours, target a mean arterial pressure of 65 mmHg with norepinephrine as the first-line vasopressor if hypotension persists after fluid resuscitation, and use a fluid challenge technique guided by frequent hemodynamic reassessment rather than fixed protocols. 1

Initial Fluid Resuscitation

The cornerstone of shock resuscitation is aggressive early fluid administration. The Surviving Sepsis Campaign 2016 guidelines provide strong evidence (strong recommendation, low quality of evidence) that at least 30 mL/kg of crystalloid should be administered within the first 3 hours 1. This is not a ceiling—some patients will require substantially more fluid, and administration should be rapid in the initial phase 1.

Fluid Selection

  • Use crystalloids as your first-line fluid (strong recommendation, moderate quality of evidence) 1
  • Either balanced crystalloids or normal saline are acceptable (weak recommendation, low quality of evidence) 1
  • Consider adding albumin when patients require substantial amounts of crystalloids (weak recommendation, low quality of evidence) 1, 2
  • Never use hydroxyethyl starches (strong recommendation, high quality of evidence) 1
  • Avoid gelatins when crystalloids are available (weak recommendation, low quality of evidence) 1

The evidence strongly favors crystalloids over colloids for initial resuscitation, with the exception that albumin may be added as a supplement when crystalloid requirements become excessive.

Hemodynamic Assessment and Monitoring

After initial fluid bolus, continuous reassessment is mandatory 1. The 2016 guidelines moved away from rigid protocolized targets (like central venous pressure 8-12 mmHg) toward dynamic assessment 2.

What to Monitor

  • Capillary refill time, skin temperature, and mottling for peripheral perfusion 3
  • Serial lactate measurements to guide resuscitation (weak recommendation, low quality of evidence) 2
  • Central venous oxygen saturation and veno-arterial CO2 gradient if central access is present 3
  • Arterial blood pressure via arterial line once shock persists beyond initial therapy or vasopressors are needed 3

Fluid Responsiveness Assessment

Before giving additional fluids after the initial 30 mL/kg, assess fluid responsiveness 3. The most recent ESICM 2025 guidelines emphasize this critical step to avoid fluid overload.

  • Use dynamic variables (pulse pressure variation, stroke volume variation) over static markers (like CVP) when applicable 2, 3
  • Echocardiography should be your first-line imaging modality to determine shock type and guide therapy 3
  • Continue fluid challenges only as long as hemodynamic parameters continue to improve 1

Common pitfall: Continuing fluid administration without assessing responsiveness leads to harmful fluid overload, which significantly increases morbidity and mortality 4.

Vasopressor Therapy

When hypotension persists despite adequate fluid resuscitation:

First-Line Agent

Norepinephrine is the first-choice vasopressor (strong recommendation, moderate quality of evidence) 1, 2

Target Blood Pressure

Target a mean arterial pressure (MAP) of 65 mmHg initially 1, 2

Second-Line Agents

If norepinephrine alone is insufficient:

  • Add vasopressin (up to 0.03 U/min) to raise MAP or decrease norepinephrine dose (weak recommendation, moderate quality of evidence) 1
  • Add epinephrine as an alternative second agent (weak recommendation, low quality of evidence) 1
  • Dopamine only in highly selected patients with low arrhythmia risk and bradycardia (weak recommendation, low quality of evidence) 1

Critical caveat: Do not use vasopressin as a single initial agent, and do not exceed 0.03-0.04 U/min except as salvage therapy 1, 2.

Source Control

Identify and control the source of infection as rapidly as possible 1, 2. This is a best practice statement with the highest priority.

  • Implement source control intervention as soon as medically and logistically practical 1
  • Use the least physiologically invasive approach (e.g., percutaneous drainage over surgical) 1, 2
  • Remove infected intravascular devices promptly after establishing alternative access 1

Cardiac Output Monitoring

Monitor cardiac output or stroke volume in patients not responding to initial therapy 3. This helps differentiate shock types and guides further management, particularly distinguishing distributive from cardiogenic shock.

Algorithmic Approach

  1. Immediate recognition: Treat shock as a medical emergency 1
  2. Initial resuscitation: 30 mL/kg crystalloid within 3 hours 1
  3. Reassess continuously: Clinical exam, vital signs, lactate, urine output 1
  4. Determine shock type: Use echocardiography 3
  5. Assess fluid responsiveness: Before additional fluids 3
  6. Initiate vasopressors: If MAP < 65 mmHg despite fluids, start norepinephrine 1, 2
  7. Source control: Identify and treat within hours 1
  8. Advanced monitoring: Arterial line, cardiac output monitoring if not responding 3

The most critical pitfall to avoid: Continuing aggressive fluid administration without assessing responsiveness, which leads to harmful fluid overload and worse outcomes. The shift from protocolized fixed targets to dynamic, individualized assessment based on continuous reassessment represents the most important evolution in shock management 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.